(Q42993083)

12 November 2017

title

Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan (English)

1 reference

12 November 2017

Liu CJ

1

1 reference

12 November 2017

Kao JH

2

1 reference

12 November 2017

Lai MY

3

1 reference

12 November 2017

Chen PJ

4

1 reference

12 November 2017

Chu JS

5

1 reference

12 November 2017

Chen W

6

1 reference

12 November 2017

Chen DS

7

1 reference

12 November 2017

language of work or name

1 reference

1 April 1999

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

14

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

352-357

1 reference

Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Hepatitis B virus and apparent fulminant non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Hepatitis C Virus in Fulminant Hepatic Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Isolation of novel virus-like sequences associated with human hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Alphabet of hepatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

GBV-C in the aetiology of fulminant hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Does GBV-C cause fulminant hepatitis in Japan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Association between fulminant hepatic failure and a strain of GBV virus C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Fulminant and subfulminant liver failure: definitions and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Detection of antibodies to a putative hepatitis G virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

An ELISA for detection of antibodies to the E2 protein of GB virus C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Intrafamilial transmission of hepatitis C virus: the important role of infections between spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Correlation of serum delta RNA with clinical course of acute hepatitis delta virus superinfection in Taiwan: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

δ Infection in asymptomatic carriers of hepatitis B surface antigen: Low prevalence of δ activity and effective suppression of hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: analyses by nucleic acid amplification method

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Early events in hepatitis C virus infection of chimpanzees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Hepatitis C virus-associated fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Detection of hepatitis B viral DNA by polymerase chain reaction in patients with hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

Studies of GB hepatitis agent in tamarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01855.X

10.1046/J.1440-1746.1999.01855.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference